168 related articles for article (PubMed ID: 15044728)
1. Molecular dynamics and free energy analysis of neuraminidase-ligand interactions.
Bonnet P; Bryce RA
Protein Sci; 2004 Apr; 13(4):946-57. PubMed ID: 15044728
[TBL] [Abstract][Full Text] [Related]
2. Analysis of inhibitor binding in influenza virus neuraminidase.
Smith BJ; Colman PM; Von Itzstein M; Danylec B; Varghese JN
Protein Sci; 2001 Apr; 10(4):689-96. PubMed ID: 11274459
[TBL] [Abstract][Full Text] [Related]
3. Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.
Swaminathan K; Downard KM
Anal Chem; 2012 Apr; 84(8):3725-30. PubMed ID: 22409142
[TBL] [Abstract][Full Text] [Related]
4. Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations.
Masukawa KM; Kollman PA; Kuntz ID
J Med Chem; 2003 Dec; 46(26):5628-37. PubMed ID: 14667217
[TBL] [Abstract][Full Text] [Related]
5. Scoring binding affinity of multiple ligands using implicit solvent and a single molecular dynamics trajectory: application to influenza neuraminidase.
Bonnet P; Bryce RA
J Mol Graph Model; 2005 Oct; 24(2):147-56. PubMed ID: 16098779
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling of T. rangeli, T. brucei gambiense, and T. evansi sialidases in complex with the DANA inhibitor.
Lima AH; Souza PR; Alencar N; Lameira J; Govender T; Kruger HG; Maguire GE; Alves CN
Chem Biol Drug Des; 2012 Jul; 80(1):114-20. PubMed ID: 22416952
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the absolute affinity of neuraminidase inhibitor using steered molecular dynamics simulations.
Tam NM; Nguyen MT; Ngo ST
J Mol Graph Model; 2017 Oct; 77():137-142. PubMed ID: 28854402
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
Varghese JN; Epa VC; Colman PM
Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
[TBL] [Abstract][Full Text] [Related]
9. A structural and energetics analysis of the binding of a series of N-acetylneuraminic-acid-based inhibitors to influenza virus sialidase.
Taylor NR; von Itzstein M
J Comput Aided Mol Des; 1996 Jun; 10(3):233-46. PubMed ID: 8808739
[TBL] [Abstract][Full Text] [Related]
10. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
Hitaoka S; Matoba H; Harada M; Yoshida T; Tsuji D; Hirokawa T; Itoh K; Chuman H
J Chem Inf Model; 2011 Oct; 51(10):2706-16. PubMed ID: 21870866
[TBL] [Abstract][Full Text] [Related]
11. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
12. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
D'Ursi P; Chiappori F; Merelli I; Cozzi P; Rovida E; Milanesi L
Biochem Biophys Res Commun; 2009 Jun; 383(4):445-9. PubMed ID: 19371724
[TBL] [Abstract][Full Text] [Related]
14. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
Hitaoka S; Harada M; Yoshida T; Chuman H
J Chem Inf Model; 2010 Oct; 50(10):1796-805. PubMed ID: 20863103
[TBL] [Abstract][Full Text] [Related]
15. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes.
Fornabaio M; Cozzini P; Mozzarelli A; Abraham DJ; Kellogg GE
J Med Chem; 2003 Oct; 46(21):4487-500. PubMed ID: 14521411
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
[TBL] [Abstract][Full Text] [Related]
17. Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Y
J Mol Model; 2010 Dec; 16(12):1809-18. PubMed ID: 20213331
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
Mai BK; Li MS
Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
20. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
